These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 373353)

  • 21. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocytotoxic antibodies and histocompatibility antigens in juvenile-onset diabetes mellitus.
    Serjeantson S; Theophilus J; Zimmet P; Court J; Crossley JR; Elliott RB
    Diabetes; 1981 Jan; 30(1):26-9. PubMed ID: 7014302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA, islet cell antibodies, and types of diabetes mellitus.
    Nerup J; Platz P; Ryder LP; Thomsen M; Svejgaard A
    Diabetes; 1978; 27 Suppl 1():247-50. PubMed ID: 344116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Total IgE synthesis in diabetic children].
    Cavagni G; Vanelli M; Nori G; Piccione AM; Bernasconi S
    Arch Fr Pediatr; 1983 Apr; 40(4):319-21. PubMed ID: 6349570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
    Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
    Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia.
    Peters WH; Lester FT; Kohnert KD; Hildmann W
    Exp Clin Endocrinol; 1986 Aug; 87(3):326-32. PubMed ID: 3536536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [4 varieties of islet cell antibodies in 74 insulin-dependent diabetics and their families as a function of the HLA genotype].
    Vexiau P; Helmy-Khalil S; Mamoun F; Homberg JC; Cathelineau G; Deschamps I; Busson M; Hors J
    Presse Med; 1986 Feb; 15(8):383-6. PubMed ID: 2938157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet cell antibodies and diabetes in Nigerians.
    Oli JM; Bottazzo GF; Doniach D
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet-cell cytoplasmic antibodies in Japanese diabetics.
    Shinjyo T; Hirata Y; Maruyama H; Ishiba S; Matuura N; Fukushima N; Wakisaka A
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():265-9. PubMed ID: 6393434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of islet cell antibody and islet cell surface antibody in diabetics].
    Iwo K
    Nihon Rinsho; 1990 Dec; 48 Suppl():300-7. PubMed ID: 2086903
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of autoimmune processes in the pathogenesis of diabetes mellitus].
    Sil'nitskiĭ PA; Shabanova LF
    Klin Med (Mosk); 1980 Oct; 58(10):22-6. PubMed ID: 7003240
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoplasmic islet cell antibodies in children with type I diabetes.
    Michalková D; Kostál M; Rajcáni J; Petrovicová A; Bircák J; Kolár J; Barák L; Hrabcáková D
    Bratisl Lek Listy; 1989 Mar; 90(3):159-67. PubMed ID: 2541873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M; Karjalainen J; Akerblom HK
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islet cell antibodies and diabetes mellitus in Pima Indians.
    Knowler WC; Bennett PH; Bottazzo GF; Doniach D
    Diabetologia; 1979 Sep; 17(3):161-4. PubMed ID: 389722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins.
    Baekkeskov S; Nielsen JH; Marner B; Bilde T; Ludvigsson J; Lernmark A
    Nature; 1982 Jul; 298(5870):167-9. PubMed ID: 7045690
    [No Abstract]   [Full Text] [Related]  

  • 40. Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first-degree relatives.
    Barbosa J; Chavers B; Dunsworth T; Michael A
    Diabetes; 1982 Jul; 31(7):585-8. PubMed ID: 6761195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.